The DOI matches its Crossref record.
First-order rate-determining aggregation mechanism of p53 and its implications
Abstract
Aggregation of p53 is initiated by first-order processes that generate an aggregation-prone state with parallel pathways of major or partial unfolding. Here, we elaborate the mechanism and explore its consequences, beginning with the core domain and extending to the full-length p53 mutant Y220C. Production of large light-scattering particles was slower than formation of the Thioflavin T-binding state and simultaneous depletion of monomer. EDTA removes Zn 2+ to generate apo -p53, which aggregated faster than holo -p53. Apo -Y220C also aggregated by both partial and major unfolding. Apo -p53 was not an obligatory intermediate in the aggregation of holo -p53, but affords a parallel pathway that may be relevant to oncogenic mutants with impaired Zn 2+ binding. Full-length tetrameric Y220C formed the Thioflavin T-binding state with similar rate constants to those of core domain, consistent with a unimolecular initiation that is unaffected by neighboring subunits, but very slowly formed small light-scattering particles. Apo -Y220C and aggregated holo -Y220C had little, if any, seeding effect on the initial polymerization of holo -Y220C (measured by Thioflavin T binding), consistent with initiation being a unimolecular process. But apo -Y220C and aggregated holo -Y220C accelerated somewhat the subsequent formation of light-scattering particles from holo -protein, implying coaggregation. The implications for cancer cells containing wild-type and unstable mutant alleles are that aggregation of wild-type p53 (or homologs) might not be seeded by aggregated mutant, but it could coaggregate with p53 or other cellular proteins that have undergone the first steps of aggregation and speed up the formation of microscopically observable aggregates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations reduce the structural stability of p53, resulting in the exposure of adhesion sequences located in the hydrophobic core and p53 aggregation.148”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [148]
In the citing paper
“Once mutated, its structural stability is compromised, exposing adhesion sequences encased in the hydrophobic core of p53, which drives the formation of p53 aggregates,481 thereby depriving p53 of its DNA recognition function and proapoptotic capacity482,483”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [481]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 20
- 10.1073/pnas.1211550109 · DOI · Paper page
- 10.1038/nchembio.131 · DOI · Paper page
- 10.1016/j.cell.2012.02.022 · DOI · Paper page
- 10.1016/j.bbapap.2008.10.016 · DOI · Paper page
- 10.1146/annurev.biochem.77.060806.091238 · DOI · Paper page
- 10.1074/jbc.M604209200 · DOI · Paper page
- 10.1016/j.jmb.2009.11.013 · DOI
- P Hainaut, J Milner, A structural role for metal ions in the “wild-type” conformation of the tumor suppressor protein p53. Cancer Res 53, 1739–1742 (1993).
- 10.1038/sj.onc.1203434 · DOI · Paper page
- 10.1021/bi026635n · DOI · Paper page
- 10.1073/pnas.94.26.14338 · DOI · Paper page
- 10.1021/ja301056a · DOI · Paper page
- 10.1093/nar/gkq800 · DOI · Paper page
- 10.1016/j.jmb.2011.03.047 · DOI
- 10.1021/jp070212j · DOI · Paper page
- 10.1021/jp8083088 · DOI
- 10.1038/nchembio.546 · DOI · Paper page
- 10.1021/ja201006s · DOI
- 10.1016/j.ccr.2012.03.042 · DOI · Paper page
- 10.1016/0003-2697(85)90409-9 · DOI · Paper page
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
Malcovati, L., Karimi, M., Papaemmanuil, E., Ambaglio, I., Jädersten, M., Jansson, M., Elena, C., Gallì, A., Walldin, G., Della Porta, M. G., et al. (2015) · Blood · doi:10.1182/blood-2015-03-633537 · Cited by 434
A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas
Soragni, A., Janzen, D. M., Johnson, L. M., Lindgren, A. G., Thai-Quynh Nguyen, A., Tiourin, E., Soriaga, A. B., Lu, J., Jiang, L., Faull, K. F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.002 · Cited by 341
p53: from understanding its structure to advances in therapeutic targeting
Wang, W., Liu, X., Liu, H., Abolhassani, H., Yan, H., Zhang, H., & Wang, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02549-5 · Cited by 30
Metadata
- Authors
- Wang, G., & Fersht, A. R.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-08-06
- Volume
- 109
- Issue
- 34
- Pages
- 13590-13595
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 69
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: First-order rate-determining aggregation mechanism of p53 and its implications. https://app.cochat.ai/papers/10.1073/pnas.1211557109
- The paper
- Wang, G., & Fersht, A. R. (2012). First-order rate-determining aggregation mechanism of p53 and its implications. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1211557109
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.